NCT07015645

Brief Summary

This study aims to assess long-term outcomes of hypopituitarism following gamma knife radiosurgery (GKRS) for pituitary adenomas.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
137

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 11, 2025

Completed
Last Updated

June 11, 2025

Status Verified

June 1, 2025

Enrollment Period

6 years

First QC Date

June 3, 2025

Last Update Submit

June 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of new-onset hypopituitarism

    Prevalence of new-onset hypopituitarism will be recorded.

    5 years post-procedure

Study Arms (1)

Pituitary Adenomas group

Patients received gamma knife radiosurgery (GKRS) treatment for pituitary adenomas.

Procedure: Gamma Knife Radiosurgery

Interventions

Patients received gamma knife radiosurgery (GKRS) treatment for pituitary adenomas.

Pituitary Adenomas group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This retrospective cohort study will be conducted in the Department of Neurosurgery, Al-Azhar University Hospital.

You may qualify if:

  • Age ≥18 years.
  • Both sexes.
  • Patients treated with gamma knife radiosurgery (GKRS).

You may not qualify if:

  • Patients with inadequate endocrine follow-up (\<12 months).
  • Patients who had undergone previous radiation therapy.
  • Pituitary insufficiency which presents before gamma knife radiosurgery (GKRS).
  • Patients without visible glands.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al-Azhar University (Damietta)

Damietta, 0000-0001-6746-3024, Egypt

Location

MeSH Terms

Conditions

HypopituitarismPituitary Neoplasms

Interventions

Radiosurgery

Condition Hierarchy (Ancestors)

Pituitary DiseasesHypothalamic DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEndocrine System DiseasesEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHypothalamic NeoplasmsSupratentorial NeoplasmsBrain NeoplasmsCentral Nervous System NeoplasmsNervous System Neoplasms

Intervention Hierarchy (Ancestors)

RadiotherapyTherapeuticsStereotaxic TechniquesNeurosurgical ProceduresSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Neurosurgery, Faculty of Medicine, Al-Azhar University, Damietta, Egypt.

Study Record Dates

First Submitted

June 3, 2025

First Posted

June 11, 2025

Study Start

January 1, 2019

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

June 11, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations